Study: Alopecia Areata FB102-701

We are currently seeking male volunteers aged 18 to 60 years and female volunteers aged 18 to 75 years who have been diagnosed with alopecia areata to participate in a clinical trial.

You will be reimbursed for reasonable expenses associated with study visits. If you are interested in finding out more information and check whether you may be eligible, please click the link below to speak with one of our recruitment specialists!

Key eligibility criteria: 

• 18 to 75 years of age 

• Diagnosis of alopecia areata 

• Weight ≥ 45 kg and ≤ 130 kg. 

This study is testing a new potential treatment for alopecia areata. Alopecia areata is an autoimmune condition that affects millions of people worldwide. Alopecia areata is characterised by patchy hair loss on the scalp and happens when the immune system mistakenly attacks the hair follicles leading to hair loss. This usually happens when the hair follicles lose their natural immune protection, often triggered by stress, infection, or other factors.  

This clinical trial is testing a new potential medicine, which is a type of antibody therapy. Normally, antibodies are made by the immune system to fight infections, but the study medication is made in a laboratory to target a specific part of the immune system response involved in alopecia areata. Participants will be reimbursed for reasonable expenses associated with study visits. 

By contacting us, you are under no obligation to take part in the study. Dermatology Institute of Victoria, 8-10 Howitt Street, South Yarra VIC 3141. Daniela Borzillo Email: clinicaltrials@div.net.au or Tel: (03) 9826 4966